Polar Asset Management Partners’s Calidi Biotherapeutics CLDI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,042
| Closed | -$12.8K | – | 719 |
|
|
2024
Q2 | $12.8K | Hold |
1,042
| – | – | ﹤0.01% | 609 |
|
|
2024
Q1 | $65.4K | Hold |
1,042
| – | – | ﹤0.01% | 533 |
|
|
2023
Q4 | $162K | Hold |
1,042
| – | – | ﹤0.01% | 466 |
|
|
2023
Q3 | $342K | Sell |
1,042
-2,398
| -70% | -$788K | 0.01% | 497 |
|
|
2023
Q2 | $4.33M | Hold |
3,440
| – | – | 0.08% | 305 |
|
|
2023
Q1 | $4.24M | Hold |
3,440
| – | – | 0.06% | 336 |
|
|
2022
Q4 | $4.2M | Sell |
3,440
-302
| -8% | -$369K | 0.05% | 432 |
|
|
2022
Q3 | $4.42M | Sell |
3,742
-15,180
| -80% | -$17.9M | 0.05% | 478 |
|
|
2022
Q2 | $22.6M | Buy |
18,922
+2,422
| +15% | +$2.89M | 0.26% | 66 |
|
|
2022
Q1 | $19.6M | Hold |
16,500
| – | – | 0.21% | 88 |
|
|
2021
Q4 | $19.4M | Buy |
+16,500
| New | +$19.4M | 0.21% | 92 |
|